2024 |
Thrombotic Risk and Calculated Whole Blood Viscosity in a Cohort of Patients With New Diagnosis of Multiple Myeloma |
Articolo in rivista |
Vai |
2024 |
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma |
Articolo in rivista |
Vai |
2024 |
The Combination of Natural Compounds Escin-Bromelain-Ginkgo Biloba-Sage Miltiorrhiza (EBGS) Reduces Platelet Adhesion to TNFα-Activated Vascular Endothelium through FAK Signaling |
Articolo in rivista |
Vai |
2024 |
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial |
Articolo in rivista |
Vai |
2024 |
A Difficult Case of Ventriculitis in a 40-Year-Old Woman with Acute Myeloid Leukemia |
Articolo in rivista |
Vai |
2024 |
Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps |
Review essay (rassegna critica) |
Vai |
2024 |
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes |
Articolo in rivista |
Vai |
2024 |
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients |
Articolo in rivista |
Vai |
2024 |
Six‐week low‐molecular‐weight heparin versus 12‐week warfarin for calf deep vein thrombosis: A randomized, prospective, open‐label study |
Articolo in rivista |
Vai |
2023 |
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance |
Articolo in rivista |
Vai |
2023 |
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again |
Review essay (rassegna critica) |
Vai |
2023 |
Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study |
Review essay (rassegna critica) |
Vai |
2023 |
Erythrocyte deformability profile evaluated by laser diffractometry in patients with multiple myeloma: Re-examination of our cases |
Articolo in rivista |
Vai |
2023 |
Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors |
Articolo in rivista |
Vai |
2023 |
IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy |
Articolo in rivista |
Vai |
2023 |
The Role of Injectables in the Treatment and Prevention of Cancer-Associated Thrombosis |
Review essay (rassegna critica) |
Vai |
2023 |
Humoral and Cell-Mediated Responses to SARS-CoV-2 Vaccination in a Cohort of Immunodeficient Patients |
Articolo in rivista |
Vai |
2023 |
Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion |
Articolo in rivista |
Vai |
2023 |
Global hemostasis assays in acute myeloid leukemia: results of an observational prospective study |
Articolo in rivista |
Vai |
2023 |
Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments |
Articolo in rivista |
Vai |
2023 |
Managing Relevant Clinical Conditions of Hemophilia A/B Patients |
Review essay (rassegna critica) |
Vai |
2023 |
Immune Cells, Cytokines, and Gut Microbiota Landscape Along Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Evolution |
Poster pubblicato in rivista |
Vai |
2023 |
Unveiling Novel Therapeutic Targets for CAR Therapy in Multiple Myeloma through Single-Cell RNA Sequencing |
Abstract in rivista |
Vai |
2023 |
Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials |
Articolo in rivista |
Vai |
2023 |
Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome |
Articolo in rivista |
Vai |
2022 |
The important impact of dental care on haemostatic treatment burden in patients with mild haemophilia |
Articolo in rivista |
Vai |
2022 |
Clostridium difficile Induced Inflammasome Activation and Coagulation Derangements |
Review essay (rassegna critica) |
Vai |
2022 |
Network meta-analysis of randomized trials in multiple myeloma efficacy and safety in frontline therapy for patients not eligible for transplant |
Articolo in rivista |
Vai |
2022 |
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity |
Articolo in rivista |
Vai |
2022 |
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol |
Articolo in rivista |
Vai |
2022 |
Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform |
Articolo in rivista |
Vai |
2022 |
Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine |
Lettera |
Vai |
2022 |
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes |
Articolo in rivista |
Vai |
2022 |
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia |
Articolo in rivista |
Vai |
2022 |
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations |
Review essay (rassegna critica) |
Vai |
2022 |
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection |
Articolo in rivista |
Vai |
2022 |
Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy |
Review essay (rassegna critica) |
Vai |
2022 |
Familial essential thrombocythemia: 6 cases from a mono‐institutional series |
Articolo in rivista |
Vai |
2022 |
Kinesiotaping for the Treatment of Haematomas in Haemophiliacs: a Case Control Study |
Articolo in rivista |
Vai |
2022 |
Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma |
Review essay (rassegna critica) |
Vai |
2021 |
Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype |
Review essay (rassegna critica) |
Vai |
2021 |
Bone damage after chemotherapy for lymphoma: a real-world experience |
Articolo in rivista |
Vai |
2021 |
Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents |
Review essay (rassegna critica) |
Vai |
2021 |
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature |
Articolo in rivista |
Vai |
2021 |
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations |
Articolo in rivista |
Vai |
2021 |
Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review |
Review essay (rassegna critica) |
Vai |
2021 |
Future directions in acquired hemophilia A |
Lettera |
Vai |
2021 |
Immune thrombocytopenia in antiphospholipid syndrome: Is it primary or secondary? |
Review essay (rassegna critica) |
Vai |
2021 |
Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy |
Recensione in rivista |
Vai |
2021 |
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis |
Articolo in rivista |
Vai |
2021 |
Comparison between whole blood viscosity measured and calculated in subjects with monoclonal gammopathy of undetermined significance and in patients with multiple myeloma: Re-evaluation of our survey |
Articolo in rivista |
Vai |
2021 |
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis |
Articolo in rivista |
Vai |
2020 |
Peripheral circulating cells with paroxysmal nocturnal haemoglobinuria phenotype after a first episode of cerebral sinus vein thrombosis: Results from a multicentre cross-sectional study |
Lettera |
Vai |
2020 |
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep |
Articolo in rivista |
Vai |
2020 |
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study |
Articolo in rivista |
Vai |
2020 |
Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series |
Articolo in rivista |
Vai |
2020 |
Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey |
Lettera |
Vai |
2020 |
Multiple Myeloma-Derived Extracellular Vesicles Induce Osteoclastogenesis through the Activation of the XBP1/IRE1α Axis |
Articolo in rivista |
Vai |
2020 |
Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience |
Articolo in rivista |
Vai |
2020 |
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? |
Articolo in rivista |
Vai |
2020 |
The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma |
Articolo in rivista |
Vai |
2020 |
Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma |
Articolo in rivista |
Vai |
2020 |
Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia? |
Articolo in rivista |
Vai |
2020 |
Plasma viscosity pattern and erythrocyte aggregation in two patients with congenital afibrinogenemia |
Lettera |
Vai |
2020 |
Quality of Life in Patients With Cancer Under Prolonged Anticoagulation for High-Risk Deep Vein Thrombosis: a Long-Term Follow-Up |
Articolo in rivista |
Vai |
2020 |
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors |
Articolo in rivista |
Vai |
2020 |
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL |
Articolo in rivista |
Vai |
2020 |
Cardiovascular risk factor in MPN patients |
Lettera |
Vai |
2020 |
Sex-related characteristics of cerebral vein thrombosis: A secondary analysis of a multicenter international cohort study |
Lettera |
Vai |
2020 |
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey |
Lettera |
Vai |
2020 |
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey |
Lettera |
Vai |
2020 |
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET |
Articolo in rivista |
Vai |
2020 |
New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey |
Articolo in rivista |
Vai |
2020 |
Immunoistochemical expression of PD-1 and PD-L1 in bone marrow biopsies of patients with acute myeloid leukemia |
Articolo in rivista |
Vai |
2020 |
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association |
Lettera |
Vai |
2019 |
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications |
Articolo in rivista |
Vai |
2019 |
Clinical implications of discordant early molecular responses in CML patients treated with imatinib |
Articolo in rivista |
Vai |
2019 |
Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry |
Articolo in rivista |
Vai |
2019 |
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry |
Articolo in rivista |
Vai |
2019 |
Fostering drug.storage,preparation and treatment modalities improves adherence to treatment with turoctocog-alfa in patients with haemophilia A:results from a short term follow-up |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia |
Articolo in rivista |
Vai |
2019 |
Personalized prophylaxis with simoctocog-alfa(human-cl rhFVIII):A real-life experience on children and moderate haemophilia A patients |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
Articolo in rivista |
Vai |
2019 |
Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogues |
Lettera |
Vai |
2019 |
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus |
Articolo in rivista |
Vai |
2019 |
Haemorheological profile in congenital afibrinogenemia and in congenital dysfibrinogenemia: A clinical case report |
Articolo in rivista |
Vai |
2019 |
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors |
Articolo in rivista |
Vai |
2019 |
Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
A case of severe dermatitis in a patient with Polycythemia Vera during cytoreductive therapy |
Articolo in rivista |
Vai |
2019 |
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors |
Articolo in rivista |
Vai |
2019 |
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario |
Lettera |
Vai |
2019 |
MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders |
Lettera |
Vai |
2019 |
Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry |
Articolo in rivista |
Vai |
2019 |
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study |
Articolo in rivista |
Vai |
2019 |
Age at diagnosis is an important prognostic factor in Philadelphia-negative Myeloproliferative Neoplasms |
Lettera |
Vai |
2019 |
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative |
Lettera |
Vai |
2019 |
Detection and clinical implications of a novel BCR-ABL1 E12A2 insertion/deletion in a CML patient expressing the E13A2 isoform |
Articolo in rivista |
Vai |
2019 |
Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia a in Italy: Characteristics and Clinical Benefits |
Review essay (rassegna critica) |
Vai |
2019 |
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review |
Articolo in rivista |
Vai |
2018 |
Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies |
Articolo in rivista |
Vai |
2018 |
Immunosenescence and lymphomagenesis |
Articolo in rivista |
Vai |
2018 |
Red blood cell deformability in multiple myeloma |
Articolo in rivista |
Vai |
2018 |
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs |
Articolo in rivista |
Vai |
2018 |
Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand? |
Articolo in rivista |
Vai |
2018 |
Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature |
Review essay (rassegna critica) |
Vai |
2018 |
Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry |
Lettera |
Vai |
2018 |
Lymphomas and thyroid: Bridging the gap |
Articolo in rivista |
Vai |
2017 |
Prolonged anticoagulant treatment in patients with cancer: Where do we stand? |
Recensione in rivista |
Vai |
2017 |
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2017 |
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2017 |
Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS) |
Articolo in rivista |
Vai |
2017 |
Cardio-oncology in multiple myeloma: is it time for a specific focus? |
Articolo in rivista |
Vai |
2017 |
Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy |
Articolo in rivista |
Vai |
2017 |
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate |
Articolo in rivista |
Vai |
2017 |
Acquired haemophilia in cancer: A systematic and critical literature review |
Review essay (rassegna critica) |
Vai |
2017 |
Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry |
Articolo in rivista |
Vai |
2017 |
Erythrocyte deformability and hemorheological profile in multiple myeloma |
Articolo in rivista |
Vai |
2016 |
Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia |
Articolo in rivista |
Vai |
2016 |
Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study |
Articolo in rivista |
Vai |
2015 |
Hematopoietic Peripheral Circulating Blood Stem Cells As an Independent Marker of Good Transfusion Management in Patients with Beta-Thalassemia |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2015 |
Cellule staminali ematopoietiche circolanti come marker indipendente di buon outcome clinico in pazienti con beta talassemia |
Proceedings |
Vai |
2015 |
Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. |
Lettera |
Vai |
2015 |
The Impact of Deep Vein Thrombosis in Critically Ill Patients: A Meta-Analysis of major clinical outcomes |
Articolo in rivista |
Vai |
2015 |
Cryopreserved platelets: from in vitro thrombin generation potential to in vivo safety |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2015 |
Management of Venous ThromboEmbolism in patients with acute leukemia at high bleeding risk: a multicenter study |
Articolo in rivista |
Vai |
2015 |
Response to Urrego et al |
Recensione in rivista |
Vai |
2014 |
Optimal Duration of Low Molecular Weight Heparin for the Treatment of
Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study. |
Articolo in rivista |
Vai |
2014 |
Le emergenze emorragiche in ematologia |
Capitolo o Saggio |
Vai |
2013 |
Rivaroxaban for thromboprophylaxis in acutely ill medical patients |
Articolo in rivista |
Vai |
2013 |
Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System |
Proceedings |
Vai |
2013 |
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. |
Articolo in rivista |
Vai |
2013 |
Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses |
Articolo in rivista |
Vai |
2013 |
An unknown cause of aortic valve stenosis: Polycythemia vera |
Articolo in rivista |
Vai |
2013 |
Cardiovascular events and intensity of treatment in polycythemia vera. |
Articolo in rivista |
Vai |
2013 |
Incidence and Management Of Venous Thrombosis In Acute Leukemia: A Multicenter Study |
Proceedings |
Vai |
2013 |
Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia |
Articolo in rivista |
Vai |
2013 |
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism |
Abstract in rivista |
Vai |
2013 |
Erythrocyte deformability in Polycythemia Vera |
Proceedings |
Vai |
2012 |
Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial. |
Abstract in rivista |
Vai |
2012 |
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA |
Proceedings |
Vai |
2012 |
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA. FINAL RESULTS OF A MULTICENTER STUDY |
Proceedings |
Vai |
2012 |
Oral Communication |
Proceedings |
Vai |
2012 |
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease |
Articolo in rivista |
Vai |
2012 |
Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry |
Abstract in rivista |
Vai |
2012 |
CD200 ANTIGEN IN B-CELL DERIVED NEOPLASMS: EXPRESSION AND CLINICAL IMPACT IN 77 CONSECUTIVE PATIENTS OF A SINGLE ISTITUTION |
Proceedings |
Vai |
2012 |
Health-related quality of life and psychological well-being in elderly patients with haemophilia |
Articolo in rivista |
Vai |
2012 |
PNEUMOCYSTIS JIROVECI PNEUMONIA IN HEMATOLOGICAL PATIENTS:
A SINGLE INSTITUTION EXPERIENCE |
Proceedings |
Vai |
2012 |
PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN
THROMBOSIS OF THE LOWER LIMBS |
Proceedings |
Vai |
2012 |
Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis |
Articolo in rivista |
Vai |
2012 |
Cancer patients requiring interruption of long-term warfarin because of surgery
or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses
of low-molecular weight heparin. |
Articolo in rivista |
Vai |
2012 |
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation -a look beyond the excellent results |
Abstract in rivista |
Vai |
2012 |
Aspirin for preventing the recurrence of venous thromboembolism |
Articolo in rivista |
Vai |
2012 |
Long term outcomes of patients with cerebral vein thrombosis: a multicenter study. |
Articolo in rivista |
Vai |
2012 |
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study |
Articolo in rivista |
Vai |
2012 |
CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS |
Proceedings |
Vai |
2012 |
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. |
Articolo in rivista |
Vai |
2012 |
Catastrophic antiphospholipid syndrome in a patient with V Leiden variant |
Articolo in rivista |
Vai |
2012 |
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) |
Articolo in rivista |
Vai |
2011 |
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature |
Articolo in rivista |
Vai |
2011 |
EGFR genomic alterations in cancer: prognostic and predictive values |
Articolo in rivista |
Vai |
2011 |
Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients. |
Articolo in rivista |
Vai |
2011 |
Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer. |
Articolo in rivista |
Vai |
2011 |
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. |
Articolo in rivista |
Vai |
2011 |
Prognostic relevance of an asymptomatic venous thromboembolism in patients with cance |
Articolo in rivista |
Vai |
2011 |
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER |
Articolo in rivista |
Vai |
2011 |
ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA |
Proceedings |
Vai |
2011 |
Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience |
Proceedings |
Vai |
2011 |
Factor VII deficiency: evidence that in minor surgery one-day replacement therapy is sufficient |
Proceedings |
Vai |
2010 |
Managing bleeding complications in patients treated with the
old and the new anticoagulants. |
Articolo in rivista |
Vai |
2010 |
Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly. |
Articolo in rivista |
Vai |
2010 |
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma |
Articolo in rivista |
Vai |
2010 |
Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. |
Articolo in rivista |
Vai |
2010 |
Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations. |
Articolo in rivista |
Vai |
2010 |
Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype |
Articolo in rivista |
Vai |
2010 |
MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms |
Articolo in rivista |
Vai |
2010 |
3 |
Proceedings |
Vai |
2010 |
Proposal and validation of a novel quantitative approach (QUEM) for the evaluation of menstrual blood losses. Preliminary implementation for the management of menorrhagia in congenital bleeding disorders. |
Proceedings |
Vai |
2010 |
Residual vein thrombosis and D-dimer for optimizing duration of anticoagulation in idiopathic deep vein thrombosis. |
Articolo in rivista |
Vai |
2010 |
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study |
Articolo in rivista |
Vai |
2010 |
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. |
Articolo in rivista |
Vai |
2010 |
Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura -haemolytic uraemic syndrome. |
Articolo in rivista |
Vai |
2010 |
Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin |
Articolo in rivista |
Vai |
2010 |
Trisomy 11: prevalence among 22 403 unique patient cytogenetic studies and clinical correlates. |
Articolo in rivista |
Vai |
2010 |
The Impact of Venous Thromboembolism In Critically Ill Patients: A Meta-Analysis of Major Clinical outcomes |
Proceedings |
Vai |
2010 |
Optimizing Tumor-Reactive γδ T Cells for Antibody-Based Cancer Immunotherapy |
Articolo in rivista |
Vai |
2009 |
Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). |
Articolo in rivista |
Vai |
2009 |
Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial |
Articolo in rivista |
Vai |
2009 |
Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions. |
Proceedings |
Vai |
2009 |
Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis |
Proceedings |
Vai |
2009 |
Long-Term Survival Data in 652 Patients with Primary Myelofibrosis or Polycythemia Vera— Trends in Recent Years. |
Proceedings |
Vai |
2009 |
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS Study |
Proceedings |
Vai |
2009 |
Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio. |
Articolo in rivista |
Vai |
2009 |
Transfusion Need at Diagnosis or Its Development During the First Year of Diagnosis in Primary Myelofibrosis: Effect On Survival and Correlation with JAK2 and TET2 Mutational Status |
Proceedings |
Vai |
2009 |
Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma. |
Proceedings |
Vai |
2009 |
How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs? |
Articolo in rivista |
Vai |
2009 |
Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. |
Articolo in rivista |
Vai |
2009 |
Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study |
Articolo in rivista |
Vai |
2009 |
Survival in young patients with intermediate/high-risk myelofibrosis: estimates derived from databases for non transplant patients. |
Articolo in rivista |
Vai |
2009 |
Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins |
Articolo in rivista |
Vai |
2009 |
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). |
Articolo in rivista |
Vai |
2009 |
Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years |
Articolo in rivista |
Vai |
2009 |
Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms |
Articolo in rivista |
Vai |
2009 |
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders |
Articolo in rivista |
Vai |
2009 |
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial |
Articolo in rivista |
Vai |
2009 |
Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy |
Articolo in rivista |
Vai |
2009 |
ACP Journal Club. Warfarin thromboprophylaxis in cancer did not reduce risk for catheter-related thrombosis. |
Articolo in rivista |
Vai |
2008 |
A commentary: To screen for calf DVT or not to screen? The highly variable practice among italian centers highlights this important and still unresolved clinical opinion. Results from the italian MASTER registry |
Articolo in rivista |
Vai |
2008 |
Terapia domiciliare della Trombosi
Venosa Profonda degli arti inferiori |
Curatela |
Vai |
2008 |
Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management |
Articolo in rivista |
Vai |
2008 |
Recurrent venous thromboembolism complicated by heparin-induced thrombocytopenia as a first manifestation of an occult cancer: a case report. |
Articolo in rivista |
Vai |
2008 |
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events. |
Articolo in rivista |
Vai |
2008 |
The MASTER registry on venous thromboembolism: description of the study cohort. |
Articolo in rivista |
Vai |
2008 |
Low molecular weight heparins as antineoplastic agents. |
Articolo in rivista |
Vai |
2008 |
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis |
Articolo in rivista |
Vai |
2008 |
Superficial venous thrombosis: Prevalence of common genetic risk factors and their role on spreading to deep veins |
Articolo in rivista |
Vai |
2008 |
Lung Immune and Coagulative Host Response in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (aeocpd). |
Proceedings |
Vai |
2008 |
Possiamo usarle in sostituzione dei cumarinici? Possiamo usarle quando pensiamo che il rischio emorragico da cumarinici sia troppo elevato? |
Curatela |
Vai |
2008 |
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression Ultrasonography (DACUS) study |
Articolo in rivista |
Vai |
2008 |
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry |
Articolo in rivista |
Vai |
2008 |
Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. |
Articolo in rivista |
Vai |
2007 |
Il dosaggio dell'inibitore |
Articolo in rivista |
Vai |
2007 |
LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY |
Proceedings |
Vai |
2007 |
Low molecular weight heparins in cancer patients: to treat thromboembolic events, the tumor, of both? |
Articolo in rivista |
Vai |
2007 |
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY |
Proceedings |
Vai |
2007 |
Deferral of assessment of pulmonary embolism |
Articolo in rivista |
Vai |
2007 |
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES |
Proceedings |
Vai |
2007 |
The risk of cardiovascular events is reduced by lowering hyperhomocysteinemia short term B vitamins therapy |
Proceedings |
Vai |
2007 |
Absence of Residual Vein Thrombosis after an Episode of Idiopathic Deep Vein Thrombosis: Short-Term Anticoagulation Is Safe. The "Extended Dacus Study". |
Proceedings |
Vai |
2007 |
PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY |
Proceedings |
Vai |
2007 |
Cancer-Related Venous Thrombosis: Residual Vein Thrombosis Improves Screening for Occult Cancer. |
Proceedings |
Vai |
2007 |
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS |
Proceedings |
Vai |
2007 |
THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE |
Proceedings |
Vai |
2007 |
The persistence of residual vein thrombosis, after an episode of deep vein thrombosis, and the risk of new overt cancer. |
Proceedings |
Vai |
2007 |
The Role of Gemtuzumab Ozogamicin in Elderly AML Patients in Complete Remission |
Proceedings |
Vai |
2007 |
The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. |
Articolo in rivista |
Vai |
2006 |
La gestione della terapia anticoagulante nelle procedure a rischio emorragico |
Curatela |
Vai |
2006 |
Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. |
Proceedings |
Vai |
2006 |
Bleeding Prophylaxis in a Child With Cleft Palate and Factor VII Deficiency: A Case Report |
Articolo in rivista |
Vai |
2006 |
D-dimer testing: advantages and limitation in emergency medicine for managing acute venous thromboembolism |
Articolo in rivista |
Vai |
2006 |
Successful Treatment of Gastrointestinal Bleeding With Recombinant Factor VIIa After Kidney Transplantation in Patients With Pancytopenia. |
Articolo in rivista |
Vai |
2006 |
Il dosaggio biologico dei fattori della coagulazione e degli inbitori del fattore VIII |
Monografia |
Vai |
2006 |
Test di I livello nella diagnostica della malattia di Von Willebrand" in "Emocoagulazione ed Emostasi |
Monografia |
Vai |
2006 |
Peri-operative bridgning therapy with low molecular weight heparin in patients requiring interruption of long-term oral anticoagulant therapy |
Proceedings |
Vai |
2006 |
Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients |
Proceedings |
Vai |
2006 |
Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus |
Proceedings |
Vai |
2006 |
Review: Long-term anticoagulation reduces recurrent venous thromboembolism |
Articolo in rivista |
Vai |
2006 |
Limited versus extended ultrasonography for the diagnosis of clinically suspected deep vein thrombosis |
Proceedings |
Vai |
2005 |
Durata ottimale della terapia antitrombotica nei pazienti oncologici: il ruolo del trombo venoso redisuo. Lo studio "Cancer DACUS" |
Curatela |
Vai |
2005 |
La profilassi chirurgica di pazienti con carenza congenita di FVII |
Curatela |
Vai |
2005 |
SUPERFICIAL VENOUS THROMBOSIS: ROLE OF GENETIC RISK FACTORS ON SPREADING TO DEEP VEINS |
Proceedings |
Vai |
2005 |
La gestione dell'embolia polmonare non massiva: nuove evidenze sulla terapia |
Monografia |
Vai |
2005 |
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial |
Proceedings |
Vai |
2005 |
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients |
Articolo in rivista |
Vai |
2005 |
Le EBPM possono sostituire il warfarin nella prevenzione secondaria del TEV? No |
Curatela |
Vai |
2005 |
The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study |
Articolo in rivista |
Vai |
2005 |
Factor V Leiden but not prothrombin G20210A mutation is a risk factor for thrombosis in patients with lymphoproliferative disease |
Proceedings |
Vai |
2005 |
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis. a randomized, controlled trial |
Articolo in rivista |
Vai |
2005 |
Un caso di emorragia gastrica post-trapianto di rene |
Curatela |
Vai |
2005 |
The Persistance of Residual Vein Thrombosis, after an Episode of Deep Vein Thrombosis, and the Risk of New Overt Cancer and Cardiovascular Disease |
Proceedings |
Vai |
2005 |
Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk |
Proceedings |
Vai |
2005 |
Clinical experience with optional vena cava filters: results of a prospective multicenter study |
Proceedings |
Vai |
2005 |
TROMBOSI PROFONDA SUPERFICIALE ED ESTENSIONE AL CIRCOLO PROFONDO: RUOLO DEI FATTORI DI RISCHIO GENETICI |
Proceedings |
Vai |
2005 |
Successful treatment of acquired haemophilia with FEIBA and Retuximab |
Proceedings |
Vai |
2005 |
Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study. |
Articolo in rivista |
Vai |
2005 |
Trombosi venosa superficiale ed estensione al circolo profondo: ruolo dei fattori di rischio genetici |
Abstract in rivista |
Vai |
2005 |
Superficial venous thrombosis: role of genetic risk factors on spreeding to deep veins |
Articolo in rivista |
Vai |
2005 |
Uso del FVIIa ricombinante nell'emorragia gastrica post trapianto renale |
Altro |
Vai |
2004 |
Superficial venous thrombosis and spreading to deep veins: role of genetic risk factors for venous thromboembolism |
Abstract in rivista |
Vai |
2004 |
Sindromi emorragiche e tromboemorragiche nella patologia oncoematologica e nel trapianto di midollo |
Curatela |
Vai |
2004 |
Thrombophilia in women with unexplained fetal loss |
Proceedings |
Vai |
2004 |
Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation |
Articolo in rivista |
Vai |
2004 |
Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT |
Articolo in rivista |
Vai |
2004 |
Evaluation of patients with thrombotic stroke by methionine loading oral curve |
Proceedings |
Vai |
2004 |
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins |
Articolo in rivista |
Vai |
2004 |
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis |
Articolo in rivista |
Vai |
2004 |
Il tromboembolismo venoso in oncoematologia |
Curatela |
Vai |
2004 |
Gastrointestinal bleeding in patients with von Willebrand disease; how long we can wait for surgery? |
Proceedings |
Vai |
2004 |
ISAM: international study on anticoagulation management. The Italian experience |
Proceedings |
Vai |
2004 |
Residual vein thrombosis assessment establishes the otpimal duration of oral anticoagulants in patients with idiopathic or provoked deep vein thrombosis |
Proceedings |
Vai |
2004 |
Markers della trombofilia nella arteriopatia cronica periferica ed eventi sichemici polidistrettuali |
Proceedings |
Vai |
2004 |
Curva da carico orale di metionina nella valutazione di pazienti affetti da patologia trombotica |
Proceedings |
Vai |
2002 |
Trombosi portale mesenterica idiopatica in paziente con doppia mutazione eterozigote del gene C677T e del gene A1298C della MTHFR |
Abstract in rivista |
Vai |